Clinical Trial

Etiology Analysis of Chronic Cough After COVID-19 Infection and Research on the Efficacy of ICS or ICS/LABA

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 16, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
This study collected 600 patients, evaluated whether patients had airway hyperreactivity, airway inflammation, specific types and allergic reactions, comprehensively analyzed and classified the causes of chronic cough in patients, and evaluated and compared the improvement of cough symptoms and quality of life after ICS or ICS/LABA treatment.
Protocol Amendment History 1 change
critical Trial status changed: Enrolling by Invitation → Unknown 2026-08-02
Trial Details
NCT Number NCT06503939
Lead Sponsor Xiangya Hospital of Central South University
Conditions Chronic Cough
Enrollment 600 participants
Start Date 2023-09-01
Primary Completion 2024-12-31 (estimated)
Study Completion 2024-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-07-16